NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Investors of record on Friday, January 25th will be given a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 annualized dividend and a yield of 3.05%. The ex-dividend date is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.02. The pharmacy operator earned $47.27 billion during the quarter, compared to the consensus estimate of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The business's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.50 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health updated its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

17 brokerages have issued 12-month price objectives for CVS Health's shares. Their predictions range from $75.00 to $104.00. On average, they anticipate CVS Health's share price to reach $91.4375 in the next twelve months. This suggests a possible upside of 39.6% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Headlines about CVS stock have been trending extremely positive recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 4.1 on InfoTrie's scale. They also assigned news articles about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.

CVS Health saw a decrease in short interest in December. As of December 14th, there was short interest totalling 11,357,418 shares, a decrease of 67.7% from the November 30th total of 35,182,217 shares. Based on an average daily volume of 12,090,071 shares, the short-interest ratio is currently 0.9 days. Approximately 0.9% of the shares of the stock are sold short. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional investors include Retirement Systems of Alabama (0.13%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.08%), Gateway Investment Advisers LLC (0.08%), Alta Capital Management LLC (0.06%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including First American Bank, DNB Asset Management AS, Factory Mutual Insurance Co., Alta Capital Management LLC, Gulf International Bank UK Ltd, Endurance Wealth Management Inc., Lodestar Investment Counsel LLC IL and Legacy Advisors LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Personal Capital Advisors Corp, Gateway Investment Advisers LLC, KAMES CAPITAL plc, Retirement Systems of Alabama, Community Trust & Investment Co., Gradient Investments LLC, Chesley Taft & Associates LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $65.52.

CVS Health has a market capitalization of $66.75 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]